FDA Investigator Ana Paulap Sandee
Ana Paulap Sandee has conducted inspections on 10 sites in 1 countries as of 29 Feb 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
10
Last Inspection Date:
29 Feb 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Ana Paulap Sandee:
Adree N Anderson,
Alan M Barker,
Anthony R Bucks,
Arsen Karapetyan,
Ashley A Mutawakkil,
Bei Y He,
Bonnie E Pierson,
Bryan S Roddy,
Carl A Huffman, III,
Chih Jung Hsu, PhD,
Constance L Richard,
Dana D Carter, SR DDS,
Danial S Hutchison,
David A Foran,
David F Graham,
David L Miser,
Dawn C Olenjack,
Deborah J Parris,
Edward E Lockwood (EEL),
Emilio O Escobar,
Eric M Mueller, PharmD,
Eric M Padgett,
Erika V Butler,
Farhana Khan,
Frank Wackes,
Georgia A Layloff,
Gordon T Wales,
Gretchen Lf Trendel,
Gwyn G Dickinson,
Hongjian Ding,
Jacob G Lutz,
Jacob W Reynolds,
James I Giefer,
James K Rice,
Janis R Armedoriz,
Jeffery A Hangartner,
Jeffrey B Moody,
Jeffry A Bernhardt,
Jimmie L Weigand,
Joseph A Piechocki,
Joseph R Lambert,
Kara L Roden,
Karen C Daugherty,
Karen M Montgomery (KMM),
Katherine M Taylor,
Kathleen B Swat,
Kellia N Hicks,
Kelly D Sheppard,
Kenneth D Bland,
Kshitij A Patkar,
Laura S Huffman,
Lisa L Gilliam,
Mary L Schuckmann,
Matthew M Schuckmann,
Matthew R Sleeter,
Michele L Glendenning,
Michele L Obert,
Michele Perry Williams,
Minerva Rogers,
Monica E Murie,
Monica M Mcclure,
Patricia L Payne,
Richard L Rutherford,
Rita K Kabaso,
Robert J Ham,
Robert R Wilson,
Robin K Reel,
Sandra A Hughes,
Sarah E Rhoades,
Shafiq S Ahadi,
Shanna R Haden,
Sherry G Bous,
Shirley J Berryman,
Shirshendu K Deb, PhD,
Steven D Kehoe,
Susanna E Ford,
Tara L Breckenridge,
Tara L Greene,
Tara L King,
Thuy T Nguyen, LCDR,
Tiara Nbrown Crosen,
Torrey M Ward,
Victoria A Wagoner,
Walsworth,
Warren J Lopicka,
Wayne D Mcgrath,
William Hallett, PhD,
Yaodong Huang,
Zachary A Bogorad,
Zhong Li, PhD
Ana Paulap Sandee's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more